|

The pharmaceutical industry is labeled as a 'sunrise' industry,
considered 'recession proof' & is seen to be part of the 'knowledge'
economy. Pharmaceutical companies' shareholders expect economic
profits to continue growing significantly. The pressure to perform
is high in a highly regulated global market that keeps getting more
& more competitive. Some 10 patent molecules, which have a sizeable
market share, are to go off-patent two years from now thus pushing
them into the generic segment. Government-led price controls, increasing
R&D and launch costs for each new product & decreasing product
life cycles puts pharma companies under pressure to reach peak sales
faster.
Effective use of IT solutions including e-business tools is widely
regarded today as increasing the competitiveness of a company. Two
major areas where IT is being used are R&D & S&D. New
drug discovery is a long process, taking almost 12 years on an average.
IT is being used in a big way in R&D in the actual research
process (AI softwares, modeling softwares) & in collaboration.
Sales & Distribution is where most IT implementations are taking
place today. The results are quick & returns quantifiable. These
include data analysis tools to optimise sales force effectiveness,
electronic detailing to augment or replace the traditional face-to-face
sales method, customer focused marketing, including e-reference
material to doctors. Many of the top pharmaceutical companies have
their own physician portals to supplement e-detailing with additional
value-added services (e.g. sample ordering and e-learning) and provide
information for e-diagnosis and prescribing.
Aventis e-Detailing Sales Call Center is known as iPhysicianNet,
which enables instant online access to Aventis sales representatives
to conduct video e-Detailing sessions that conveniently deliver
real-time answers to physicians' questions via their computers.
It provides on-demand information about Aventis' products, including
several mode-of-action videos. It "complements office visits
from field representatives by improving the frequency and quality
of interaction with physicians so they can ultimately make more
informed decisions regarding patient care", according to an
Aventis press release.
BabyCenter, L.L.C. is a J&J group company, serving the needs
of parents and parents-to-be. The BabyCenter family of websites
provide thousands of online articles and interactive tools, an online
baby store featuring thousands of products for purchase, and the
largest online community for parents and parents-to-be. The websites
include www.babycenter.com,
www.babycentre.co.uk &
www.parentcenter.com.
Johnson & Johnson Gateway, L.L.C.(www.jnjgateway.com),
develops and manages the Web-based resource of information created
for health care professionals by Johnson & Johnson medical devices
and diagnostics companies. The information provided by J&J on
its various websites include product information, clinical content,
professional education, patient materials, and in many countries,
e-commerce transaction and inquiry capabilities.
Merck & Co., Inc. operates Merckmedicus.com
which provides physicians and other health care providers with access
to complete texts of high-quality medical references, literature
searches, clinical information, medical news, technology reviews
and cutting-edge diagnostic tools and also features an independent
site with Continuing Medical Education (CME) courses. This comprehensive
website complements the image of Merck, which gave the pharmaceutical
industry the Merck Manual.
These medical information portals are not the only initiatives.
Merck Medco's other web-based innovations include merckmedco.com,
the world's largest online drugstore; MMRxConsultant.com,
a benefits consultant site used to benchmark performance; and the
Pharmacy Resource Center, which provides information and tools to
help pharmacists process their customers' claims.
Similarly, the Cross Functional Process Design (CFPD) group of the
IT department, GSK, is leading the effort to achieve $100 million
in savings for GSK by improving process efficiency through web technology.
An example in this direction is the B2B Web site (http://www.gsk-ecs.com/)
for its U.S. pharmaceutical wholesale and retail trade customers.
GSK's goal is to eventually eliminate all of the paper, fax and
phone transactions that have historically been conducted between
GSK and its corporate customers.
www.WeightRisks.com is
an interactive web site by Pfizer Inc., designed to educate people
about the short and long term health risks associated with gaining
weight and being overweight, an issue relevant to 97 million Americans
or 55% of the US adult population. Pfizer has other informative
websites like pfizerforwomen.com.
These & many other companies have some or the other information
based website. Many of them attract a good no. of targeted visitors.
There is still scope for websites like these. A survey by Merck
revealed that a majority of physicians still rate physician-focused
Web sites as average or below in terms of ease of use and overall
comprehensiveness. Physicians responding to the survey clearly indicated
that they are not fully satisfied with medical information on the
Internet, with only 12 percent stating that current offerings are
"excellent" in terms of providing accurate and credible
information that doctors can rely on.
The decision for advertising online is not a very straightforward
one. Calculating ROI on such ventures is very difficult. Direct
advertisement/selling from such informative sites is either unethical
or prohibited by law. In fact the same survey by Merck points out
that physicians judge the unbiased nature of information by the
(absence of) advertisements on the website. Websites like http://www.gsk-ecs.com/
which aim at eliminating paperwork are better candidates for ROI.
However, a difficult ROI measurement should not be a criteria for
stalling a project. Informative portals can be a powerful tool for
gathering information on physician's needs & interests, usually
not possible from any other source. Critical prescriber attributes
like interest in side effects versus dosing, choice of formulations,
etc. can be determined through data mining of server log files,
path analysis, and attitudinal surveys. Information like these can
be valuable in better aligning marketing strategies & achieving
peak sales faster.
your
comments on the article
contact
the author
Share the wealth!
If you know colleagues who would be interested in this newsletter,
please direct them to http://www.webizus.com/newsletter.html
To unsubscribe from the monthly newsletter, click
on the link below to e-mail your request to us. YOU WILL RECEIVE
NO FURTHER NEWSLETTERS from Webizus Technologies if you do.
newsletter@webizus.com?subject=unsubscribe
Webizus takes your privacy seriously. To learn more
about Webizus' use of personal information, please read our Privacy
Policy at http://www.webizus.com/privacy.html
Disclaimer:
Webizus through the content published makes no warranties or guarantees
about the products/ services represented or about the articles presented
in the newsletter. The articles by various authors are entirely
their own opinion. Webizus holds no responsibility to any damage
or loss incurred in any form to any person or organization due to
the publication of any of the issues.
Copyright ©1999-2002, Webizus Technologies, All
Rights Reserved.
For more information mail us on info@webizus.com
Contact us today for a demonstration of how we can
cut down your costs and improve your business:
Email us at: info@webizus.com
or call us at +91-9821634476 / +91-22-55910132
Download
our corporate profile
|
 



















|